Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?

समान संसाधन

• Stopping or Reporting Early for Positive Results in Randomized Clinical Trials: The National Cancer Institute Cooperative Group Experience From 1990 to 2005
  द्वारा: Korn, Edward L., और अन्य
  प्रकाशित: (2009)
• Design Issues in Randomized Phase II/III Trials
  द्वारा: Korn, Edward L., और अन्य
  प्रकाशित: (2012)
• Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation
  द्वारा: Freidlin, Boris, और अन्य
  प्रकाशित: (2013)
• Accrual Experience of National Cancer Institute Cooperative Group Phase III Trials Activated From 2000 to 2007
  द्वारा: Korn, Edward L., और अन्य
  प्रकाशित: (2010)
• Outcome-Adaptive Randomization: Is It Useful?
  द्वारा: Korn, Edward L., और अन्य
  प्रकाशित: (2011)